baxter
Baxter expands US portfolio with new injectables
April 12, 2024Medical Communications Pharmacy, baxter, injectables, product launch
Baxter International has announced the continued expansion of its pharmaceuticals portfolio with the launch of five new injectable products in …
Baxter partners up with Mayo Clinic for new “centre of exellence” in renal care
October 4, 2018Research and Development Mayo Clinic, baxter, kidney disease, pharma, renal
American pharma firm Baxter has announced a new partnership with the Mayo Clinic in a bid to establish a “renal …
Baxter hikes 2016 earnings view driven by strong Q1 results
April 27, 2016Research and Development, Sales and Marketing Baxalta, FY, Q1, baxter, earnings, outlook, results, revenue
Baxter International (NYSE: BAX) reported better-than-expected first-quarter profits and raised its earnings outlook for 2016. The company now sees earnings …
Baxter to cut stake in Baxalta
March 17, 2016Business Services, Sales and Marketing Baxalta, Shares, Stake sale, baxter
Baxalta Inc (NYSE: BXLT) said former parent company Baxter International (NYSE: BAX) is set to cut its stake in the …
Baxter names José Almeida chairman and chief executive
October 29, 2015Manufacturing and Production, Research and Development, Sales and Marketing Joe Almeida, José Almeida, baxter
Baxter has named José (Joe) Almeida as the company’s new chairman and chief executive from January 1, 2016. Almeida will …
Baxter recalls saline after mould contamination
October 6, 2015Manufacturing and Production baxter
Following a number of recalls earlier this year, Baxter has recalled potentially a further 140,000 bags of sodium chloride due …
Shire goes public with rejected $30bn Baxalta bid
August 5, 2015Research and Development, Sales and Marketing Baxalta, Shire, acquisitions, baxter, mergers, rare disease
Shire has confirmed that it made an all-share $30 billion offer to buy Baxalta last month, citing ’a strong strategic …
Baxter buys cancer portfolio for $900 million
May 13, 2015Research and Development, Sales and Marketing Cancer, Oncaspar, Sigma-Tau Finanziaria, baxter, oncology
Baxter is buying leukaemia treatment Oncaspar from Italian firm Sigma-Tau Finanziaria for $900 million as the US firm looks to …
Manufacturing woes hit Baxter again
April 14, 2015Manufacturing and Production, Sales and Marketing FDA, Gemünden, Pfizer, alesse, baxter, manufacturing, recall, vectura group
Baxter is voluntarily recalling several lots of intravenous solutions due to the potential presence of particulate matter. The news has …
Baxter’s haemophilia drug performs
March 17, 2015Sales and Marketing BAX 817, VIIa, baxter, haemophilia, rFVIIa
Baxter International has reported positive Phase III clinical trial results for its investigational haemophilia drug BAX 817. The recombinant factor VIIa …
Astellas appoints comms head from Baxter
September 18, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas, Burson-Marsteller, Edelman, baxter, christy noland, including GolinHarris
Astellas has hired Christy Noland to be its new director of business communications and advocacy for its urology unit in …
Baxter takes R&D head from Merck Serono
July 15, 2014Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Merck Serono, baxter, john orloff
Baxter International has appointed Dr John Orloff as its vice president and global head of R&D development for Baxter BioScience. …
Baxter to split in two next year
March 28, 2014Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, baxter, biopharma, gambro
Baxter is taking a plunge into the world of restructuring by splitting into two entities: one which is yet to …
Baxter warned by FDA over repeat failings at two plants
June 14, 2013Manufacturing and Production FDA, baxter
Baxter has attracted the ire of the US Food and Drug Administration over quality failures at two sterile product manufacturing …
Pharma manufacturing news in brief
May 29, 2012Manufacturing and Production Adienne Pharma & Biotech, Hospira, Neuroptis Biotech, Provence Technologies, Selexis and Florida Biologix, baxter
Hospira overfilled Carpuject cartridges, high-potency certification at Baxter, plus updates from Provence Technologies, Selexis and Florida Biologix.
Latest content
Santen joins inaugural Global Summit for Eye Health as partner
